Canadian Government Launches Cannabis and Brain Health Consortium
- The Canadian government is investing $24 million to create the Canadian Cannabis and Brain Health Consortium, with 10 multidisciplinary research teams studying cannabis' therapeutic potential and its effects on brain health, sleep, prenatal exposure, and certain medical conditions like psychosis, PTSD, and epilepsy.
- Health Minister Marjorie Michel stated that the investment aims to unite researchers nationwide to improve understanding of cannabis' impact on brain health, informing care, policy, and supporting Canadian health.
- Dr. Patricia Conrod highlighted that the consortium will enhance knowledge of cannabis' effects across all life stages, guiding prevention, care, and evidence-based policies long-term.
- Following the 2018 broad legalization of cannabis, over one in three Canadian adults reported cannabis use in 2025; the consortium addresses key knowledge gaps identified in the 2024 Legislative Review of the Cannabis Act.
The Canadian government is investing $24 million to establish the Canadian Cannabis and Brain Health Consortium. The new consortium will include 10 multidisciplinary research teams that will investigate topics ranging from the therapeutic potential of cannabis to its effects on brain health, sleep, prenatal exposure, and among people with conditions such as psychosis, post-traumatic stress disorder, and epilepsy.
In a statement, Minister of Health Marjorie Michel said the investment “will bring together researchers from across the country to advance our understanding of how cannabis affects brain health and generate knowledge that helps improve care, inform policy and supports the health of Canadians.”
Dr. Patricia Conrod, scientific director for the Canadian Institutes of Health Research Institute of Neurosciences, Mental Health and Addiction, said in the statement that the consortium “will help researchers build a stronger understanding of how cannabis affects people’s health at every stage of life, generating knowledge that can guide prevention, care and evidence-informed policies for years to come.”
In 2025, more than one in three Canadian adults reported consuming cannabis, and the 2024 Legislative Review of the Cannabis Act examined how the broad legalization of cannabis in 2018 has impacted the country. The consortium is meant to address key knowledge gaps identified in that review.